It has been shown from clinical studies that HCC samples derived from cancers attributable to HBV or HCV and/or exposure to aflatoxin B1 frequently exhibit a point mutation at the third position of codon 249 serine in TP53.29, 31. The gene discussed is TP53; the disease is hepatocellular carcinoma.